(Q36484723)

English

Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma (English)

1 reference

Europe PubMed Central

14 August 2017

metastatic melanoma

1 reference

based on heuristic

inferred from title

Steven Rosenberg

1

object named as

Steven A Rosenberg

1 reference

Europe PubMed Central

14 August 2017

4

object named as

Patrick Hwu

1 reference

Europe PubMed Central

14 August 2017

Suzanne L. Topalian

5

object named as

Suzanne L Topalian

1 reference

Europe PubMed Central

14 August 2017

author name string

James C Yang

2

1 reference

Europe PubMed Central

14 August 2017

Douglas J Schwartzentruber

3

1 reference

Europe PubMed Central

14 August 2017

Richard M Sherry

6

1 reference

Europe PubMed Central

14 August 2017

Nicholas P Restifo

7

1 reference

Europe PubMed Central

14 August 2017

John R Wunderlich

8

1 reference

Europe PubMed Central

14 August 2017

Claudia A Seipp

9

1 reference

Europe PubMed Central

14 August 2017

Linda Rogers-Freezer

10

1 reference

Europe PubMed Central

14 August 2017

Kathleen E Morton

11

1 reference

Europe PubMed Central

14 August 2017

Sharon A Mavroukakis

12

1 reference

Europe PubMed Central

14 August 2017

Linda Gritz

13

1 reference

Europe PubMed Central

14 August 2017

Dennis L Panicali

14

1 reference

Europe PubMed Central

14 August 2017

Donald E White

15

1 reference

Europe PubMed Central

14 August 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

14 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

14 August 2017

9

1 reference

Europe PubMed Central

14 August 2017

2973-2980

1 reference

Europe PubMed Central

14 August 2017

8

1 reference

Europe PubMed Central

14 August 2017

Progress in human tumour immunology and immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

30 September 2017

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

30 September 2017

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

30 September 2017

Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

30 September 2017

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

30 September 2017

Antigen processing in vivo and the elicitation of primary CTL responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

30 September 2017

Route of immunization and the therapeutic impact of recombinant anticancer vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

30 September 2017

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

30 September 2017

Formation of Lentivirus Particles by Mammalian Cells Infected with Recombinant Fowlpox Virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

28 June 2018

Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259234

28 June 2018

Induction of tumor-reactive cytotoxic T-lymphocytes using a peptide from NY-ESO-1 modified at the carboxy-terminus to enhance HLA-A2.1 binding affinity and stability in solution

1 reference

https://pubmed.ncbi.nlm.nih.gov/12912944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis of nuclear-associated proteins by lymphocytes within minutes after contact with phytohemagglutinin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12912944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/12912944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/12912944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues

1 reference

https://pubmed.ncbi.nlm.nih.gov/12912944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/12912944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response

1 reference

https://pubmed.ncbi.nlm.nih.gov/12912944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12912944

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36484723&oldid=1906283262"